Spinraza's Developers Disappointed With Canadian Agency & SMA as Part of Self Identity

Mar 22, 2019, 12:00 AM

We discuss how the developers of Spinraza are disappointed with a Canadian agency’s updated recommendation. Also, Community Editor Kevin Schaefer reads from his latest column, in which he talks about SMA as a part of his identity.

Are you interested in understanding gene therapy? ExploreGeneTherapy.com has helpful information about gene therapy, including its history and how it is being investigated for the treatment of genetic diseases. Visit www.exploregenetherapy.com

We discuss how the developers of Spinraza are disappointed with a Canadian agency’s updated recommendation. Also, Community Editor Kevin Schaefer reads from his latest column, in which he talks about SMA as a part of his identity. Are you interested in understanding gene therapy? ExploreGeneTherapy.com has helpful information about gene therapy, including its history and how it is being investigated for the treatment of genetic diseases. Visit www.exploregenetherapy.com